ft 21 apr 92 queen award 1992 17 tast triumph glaxo glaxo pharmaceut group uk biggest compani market capitalis fifth award technolog antibiot zinnat zinnat develop drug class need inject therefor littl use outsid hospit environ addit bacteria build resist exist antibiot penicillin prove increasingli less effect challeng glaxo develop drug pleasant swallow activ ingredi within zinnat cefuroxim axetil extrem unpleas tast stabl water retain potenc within stomach gut resist enzym gut could ingest effect bodi quick act taken blood stream without toxic product therefor without seriou side effect abl resist beta lactamas substanc excret bacteria prevent antibiot work effect glaxo believ test mani 10 000 differ formul greenford research centr north west london period six year discov right drug pharmacist also invent new process manufactur wax coat around drug coat unpleas tast dissolv requir gut releas activ ingredi sinc launch 1987 25m peopl treat drug zinnat use larg number infect rang upper respiratori infect tonsil sinus urinari tract infect gonorrhoea clinic trial show cure improv achiev 88 per cent patient lower respiratori infect 90 per cent patient gonorrhoea zinnat also low incid side effect pound 500m sale gener drug sinc launch accord glaxo make second best sell antibiot class previou award technolog ventolin becotid asthma drug zantac ulcer treatment world best sell medicin fortum anoth antibiot glaxo spent nearli dollar 4bn research develop last 10 year last fiscal year alon glaxo spent dollar 880m research develop expect analyst spend dollar 1bn compani nearest rival probabl merck us